Login to Your Account

Recursion lands $60M series B to fund AI-driven drug repurposing

By Michael Fitzhugh
Staff Writer

Tuesday, October 3, 2017

Recursion Pharmaceuticals Inc., a biotech company leveraging artificial intelligence to discover new therapies, has raised a $60 million series B financing led by the Silicon Valley-based venture firm Data Collective.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription